Company news
enVVeno Medical Corporation news in 2022
enVVeno Medical Corporation's news releases, calls and decks from 2022, newest first.
Positive 3-Year VenoValve(R) First-in-Human Data Presented at 49th Annual VEITH Symposium on Vascular and Endovascular Issues
November 16, 2022
enVVeno Medical Successfully Passes Preliminary FDA Safety Review for the VenoValve U.S. Pivotal Study
November 6, 2022
enVVeno Medical Reports Third Quarter 2022 Financial Results and Provides Corporate Update
October 26, 2022
enVVeno Medical Announces the Development of a Transcatheter Based Replacement Venous Valve for the Treatment of Chronic Venous Insufficiency
September 20, 2022
enVVeno Medical to Host Conference Call and Webcast on September 21, 2022
September 18, 2022
enVVeno Medical Appoints Kevin Belteau as Vice President of Clinical Operations
August 15, 2022
enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 2, 2022
enVVeno Medical Announces the Issuance of a New Unique Category III CPT Code Covering the Insertion of a Bioprosthetic Valve into the Femoral Vein
July 7, 2022
enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 1, 2022
enVVeno Medical Announces New U.S. VenoValve(R) Patent
April 10, 2022
enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
March 27, 2022
enVVeno Medical Announces ISO 13485 Certification
February 15, 2022